Gavin Hirst
Direttore Tecnico/Scientifico/R&S presso TURG POIN
Provenienza dei contatti di primo grado di Gavin Hirst
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
34
| Subsidiary | Pharmaceuticals: Major | 34 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gavin Hirst tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Sales & Marketing | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Founder Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member President | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| San Diego State University | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Irvine | College/University | Doctorate Degree Masters Business Admin | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Founder | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Chairman Chief Executive Officer | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member President | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Chief Operating Officer | |
Bonti, Inc.
 Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
TPG Capital LP
 TPG Capital LP Financial ConglomeratesFinance TPG Capital LP provides financial investment services. The company was founded by David Bonderman, William S. Price III and James George Coulter Jr. and is headquartered in Houston, TX. | Financial Conglomerates | Corporate Officer/Principal | |
Lucile Salter Packard Children's Hospital at Stanford
 Lucile Salter Packard Children's Hospital at Stanford Hospital/Nursing ManagementHealth Services Lucile Salter Packard Children''s Hospital at Stanford engages in the provision of hospital services. It focuses on the obstetric and pediatric areas: brain and behavior, cancer, heart, pregnancy and newborn, pulmonary, and transplant. Its practices and services include anesthesia, cancer and blood diseases, cardiology, cardiovascular intensive care, dialysis, labor and delivery, neonatology, perinatal diagnostic center, pharmacy services, pulmonary function laboratory, radiology, rehabilitation services, social services, speech and language, and before and after surgical care. The company was founded in 1991 and is headquartered in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
| Envision Rx Options Holdings, Inc. | Director/Board Member | ||
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Pharmaceuticals: Major | Director/Board Member | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Envision Pharmaceutical Services LLC
 Envision Pharmaceutical Services LLC Insurance Brokers/ServicesFinance Envision Pharmaceutical Services LLC provides pharmacy benefits management services. Its services include pharmacy benefit management, pharmacies, savings programs, insurance and clinical care and member engagement. The company was founded by James Mindala, Kevin M. Nagle and Barry Katz in 2001 and is headquartered in Twinsburg, OH. | Insurance Brokers/Services | Director/Board Member | |
Packard Children's Health Alliance
 Packard Children's Health Alliance Hospital/Nursing ManagementHealth Services Packard Children's Health Alliance operates a medical and surgical hospital for children. The private company is based in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| University of Oxford | College/University | Graduate Degree | |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | President | |
| IGNYTA INC | Biotechnology | Director of Finance/CFO | |
| RENTPATH INC | Internet Software/Services | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Irlanda | 2 |
| Canada | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 10 |
| Finance | 6 |
| Technology Services | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 189 |
| Independent Dir/Board Member | 73 |
| Corporate Officer/Principal | 59 |
| Undergraduate Degree | 29 |
| Chairman | 25 |
Contatti più connessi
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Carol Gallagher | 39 |
| Clarence Machado | 30 |
| Simeon George | 23 |
| Mark Alles | 20 |
| Sheila Gujrathi | 20 |
| Jacob Chacko | 18 |
| Barbara Bodem | 16 |
| Mohammad Hirmand | 14 |
| Garry Nicholson | 14 |
| Annette C. North | 11 |
| Raymond Furey | 11 |
| Siegfried Reich | 8 |
| Adam Levy | 8 |
| Kimberly McCutcheon Jablonski | 8 |
- Borsa valori
- Insiders
- Gavin Hirst
- Connessioni Società
